Endocrinology, Vol 128, 2752-2760, Copyright © 1991 by Endocrine Society

ARTICLES

Biochemical and morphological analysis of the interaction of epidermal growth factor and parathyroid hormone with UMR 106 osteosarcoma cells

SM Bernier, MF Rouleau and D Goltzman
Calcium Research Laboratory, McGill University, Montreal, Quebec, Canada.

The interaction of epidermal growth factor (EGF) and PTH with UMR 106 osteosarcoma cells was examined biochemically and morphologically. EGF inhibited PTH-stimulated adenylate cyclase activity in association with a reduction in PTH receptors and a decrease in the activity of the stimulatory guanyl nucleotide-binding protein (Gs). Universal inhibition of agonist-stimulated adenylate cyclase activity did not occur, inasmuch as EGF did not reduce prostaglandin E2-enhanced enzyme activity. The influence of EGF on PTH action correlated with its effect in the UMR 106 cell population of promoting entry into the cell cycle. Morphological analysis with radioautography indicated that both EGF and PTH receptors could be colocalized to certain UMR 106 cells, but that each were more abundantly distributed over discrete UMR 106 cell types. Based on the distribution of [3H]thymidine incorporation, EGF receptors were predominantly found over rapidly proliferating cells, whereas PTH receptors were most densely distributed over more quiescent cells. The results indicate that EGF and PTH receptors are localized over specific types within the heterogeneous population of UMR 106 cells and suggest that EGF may reduce PTH action in these cultures by enhancing the proliferation of progenitor cells lacking PTH receptors and reducing differentiation in this cell population, which leads to PTH receptor- enriched target cells. EGF and PTH receptors may, therefore, be useful as probes to examine both functional interactions and differentiation pathways among cells in osteoblast models in vitro and perhaps in vivo.

This article has been cited by other articles:

				C.-K. Yeh, T. K. Hymer, A. L. Sousa, B.-X. Zhang, M. D. Lifschitz, and M. S. Katz Epidermal growth factor upregulates beta -adrenergic receptor signaling in a human salivary cell line Am J Physiol Cell Physiol, May 1, 2003; 284(5): C1164 - C1175. [Abstract] [Full Text] [PDF]

				A. Azarani, D. Goltzman, and J. Orlowski Structurally Diverse N-terminal Peptides of Parathyroid Hormone (PTH) and PTH-related Peptide (PTHRP) Inhibit the Na+/H+ Exchanger NHE3 Isoform by Binding to the PTH/PTHRP Receptor Type I and Activating Distinct Signaling Pathways J. Biol. Chem., June 21, 1996; 271(25): 14931 - 14936. [Abstract] [Full Text] [PDF]

				A. Azarani, J. Orlowski, and D. Goltzman Parathyroid Hormone and Parathyroid Hormone-related Peptide Activate the Na[IMAGE]/H[IMAGE] Exchanger NHE-1 Isoform in Osteoblastic Cells (UMR-106) via a cAMP-dependent Pathway J. Biol. Chem., September 29, 1995; 270(39): 23166 - 23172. [Abstract] [Full Text] [PDF]

				A. Azarani, D. Goltzman, and J. Orlowski Parathyroid Hormone and Parathyroid Hormone-related Peptide Inhibit the Apical Na[IMAGE]/H[IMAGE] Exchanger NHE-3 Isoform in Renal Cells (OK) via a Dual Signaling Cascade Involving Protein Kinase A and C J. Biol. Chem., August 25, 1995; 270(34): 20004 - 20010. [Abstract] [Full Text] [PDF]